Andreas Mades

668 citations
6 papers · 516 · 1 hit paper · h-index 5

Impact in

  • Oncology top 10%
    • CAR-T cell therapy research
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses

Papers in

    • CAR-T cell therapy research 5
    • CRISPR and Genetic Engineering 1
    • Viral Infectious Diseases and Gene Expression in Insects 1

Andreas Mades

6 papers receiving 512 citations

Andreas Mades's Hit Papers

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells 2019 · 379 citations
3790+2+4Years since publication100200300

Peers

Andreas Mades
Comparison fields: 5 of 41
  • Oncology 430
  • Immunology 140
  • Genetics 157
  • Biomedical Engineering 181
  • Molecular Biology 180
Replace Silke Frenz with:
Silke Frenz Germany
Katrin Mestermann Germany
Benjamin Draper United Kingdom
Claudia Geldres United States
Simon Loff Germany
Andrea V. Lopez United States
Ian R. Hardy United States
Alexandra Kegler Germany
Mohamed-Reda Benmebarek Germany
Jolanta Stefanski United States
Andreas Mades relative to Silke Frenz Germany Silke Frenz's profile →
Citations per field
00.5×1.5×
Silke Frenz · 1×
Citations per year

Countries citing papers authored by Andreas Mades

Since Specialization
Citations

This map shows the geographic impact of Andreas Mades's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Mades with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Mades more than expected).

Fields of papers citing papers by Andreas Mades

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Mades. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Mades. The network helps show where Andreas Mades may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas Mades, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas Mades Line = papers co-authored together Andreas Mades links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Hit paper breakdown →
2019379
2 201965
3 201852
4 201212
5 20157
6 20181

About Andreas Mades

Andreas Mades is a scholar working on Oncology, Molecular Biology, Genetics, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 6 papers that have together received 516 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Virus-based gene therapy research (3 papers), Biosimilars and Bioanalytical Methods (1 paper), Hematopoietic Stem Cell Transplantation (1 paper), Cellular transport and secretion (1 paper), CRISPR and Genetic Engineering (1 paper), Endoplasmic Reticulum Stress and Disease (1 paper) and Viral Infectious Diseases and Gene Expression in Insects (1 paper). The work is most often cited by research in Oncology (430 citations), Immunology (140 citations), Genetics (157 citations), Biomedical Engineering (181 citations) and Molecular Biology (180 citations). Andreas Mades has collaborated with scholars based in Germany and United States. Frequent co-authors include Michael Hudecek, Hermann Einsele, Silke Frenz, Katrin Mestermann, Michel Sadelain, Justus Weber, Theodoros Giavridis, Julian Rydzek, Thomas Nerreter and Christoph Rader. Their work appears in journals such as Blood, Science Translational Medicine, International Journal of Cancer, Nature Biotechnology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact